🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nathan W. Furukawa

Centers for Disease Control and Prevention

ORCID: 0000-0002-4268-0556

Also affiliated with National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Estimated Number of People Who Inject Drugs in the United States

Clinical Infectious Diseases(2022)10.1093/cid/ciac543
Top 4%
5.0DataRank
Top 4%163 citations

Eric Hall, Alice Asher, Nathan W. Furukawa, Christopher M. Jones, Jalissa Shealey +5 more

Papers

Driven by 7 papers — median percentile 96. Top paper: “Estimated Number of People Who Inject Drugs in the United States”.

Estimated Number of People Who Inject Drugs in the United States

Clinical Infectious Diseases(2022)10.1093/cid/ciac543
Top 4%
5.0DataRank
Top 4%163 citations

Eric Hall, Alice Asher, Nathan W. Furukawa, Christopher M. Jones, Jalissa Shealey +5 more

Evaluation of Algorithms Used for PrEP Surveillance Using a Reference Population From New York City, July 2016–June 2018

Public Health Reports(2020)10.1177/0033354920904085
N/A
0.561DataRank · unranked
41 citations

Dawn K. Smith, Charles J. Gonzalez, Ya-Lin A Huang, David B. Hanna, Uriel R. Felsen +4 more

Sexuality Disclosure in U.S. Gay, Bisexual, and Other Men Who Have Sex With Men: Impact on Healthcare-Related Stigmas and HIV Pre-Exposure Prophylaxis Denial

American Journal of Preventive Medicine(2020)10.1016/j.amepre.2020.02.010
N/A
0DataRank · unranked
49 citations

Jessica L. Maksut, María Zlotorzynska, Travis Sanchez, Dawn K. Smith, Stefan Baral +1 more

CDC’s New Hepatitis C Virus Testing Recommendations for Perinatally Exposed Infants and Children: A Step Towards Hepatitis C Elimination

Journal of Women s Health(2024)10.1089/jwh.2023.1114
N/A
0DataRank · unranked
3 citations

Kathryn Miele, Emily J. Cartwright, Saleem Kamili, Nathan W. Furukawa, Kate R. Woodworth +5 more

Temporal trends in hepatitis C incidence among people tested more than once in Georgia, 2017–23: a nationwide, retrospective cohort

˜The œLancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00124-4
N/A
0DataRank · unranked
0 citations

Shaun Shadaker, Nathan W. Furukawa, Vladimer Getia, Maia Tsereteli, Hasan Symum +4 more

Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use–Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak—Cincinnati/Northern Kentucky, 2017–2018

Clinical Infectious Diseases(2020)10.1093/cid/ciaa507
N/A
0DataRank · unranked
28 citations

Erin F. Blau, Zach Reau, David Carlson, Zachary D Raney, Tisha Johnson +10 more

National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018

Annals of Internal Medicine(2020)10.7326/m20-0786
N/A
0DataRank · unranked
20 citations

Weiming Zhu, Ya-Lin A. Huang, Ram K. Shrestha, Karen W. Hoover, Nathan W. Furukawa